Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$9.02 - $12.93 $159,067 - $228,020
-17,635 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$9.3 - $25.16 $82,239 - $222,489
8,843 Added 100.58%
17,635 $167,000
Q2 2020

Aug 14, 2020

BUY
$15.99 - $22.88 $140,584 - $201,160
8,792 New
8,792 $202,000

Others Institutions Holding CNTG

About Centogene N.V.


  • Ticker CNTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,081,600
  • Market Cap $2.98M
  • Description
  • Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...
More about CNTG
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.